A Neko Health investor on the $700M bet to scan your whole body

0:00Dominic-Madori Davis: This episode of Equity is brought to you by Schneider Electric. Schneider Electric, advancing energy tech.

0:05Farooq Abbasi: Hello and welcome back to Equity, TechCrunch's flagship podcast about the business of startups. I'm Dominic-Madori Davis, in for Rebecca Balon, and this is the episode where we bring on industry experts to help us explore a trend in the tech world and dive deep. Spotify's founder has built a company that scans your body, draws your blood, and tells you your biological age in an hour. The startup, Daniel X Neco Health, recently raised a$700 million Series C. And it's not a loan. Mid Journey is building its own body scanner, and Function Health took on a$450 million loan to fund its growth. So is this the future of Madison or the most expensive wellness fad yet?

0:40Farooq Abbasi: To help us make sense of it, we're joined by someone who has seen this from a few angles, Baruch Abassi, founder and general partner of Preface Ventures. He's invested in more than 100 companies, including Neco Health, and he's even been through a Neco scan himself.

0:57Dominic-Madori Davis: Thank you so much for having me. Yeah, I have maybe just a little bit of a background, if that's helpful. So yeah, I've been venture investing for about 20 years. And by the way, healthcare and wellness and artificial intelligence is really having a renaissance and revolution. And for a lot of different reasons, we'll get into. So Preface was founded in 2016. We're investing out of our fourth fund. We'll invest at Seed, and then we'll continue to invest further and further and further into the company, up to the tunes of tens of millions or even hundreds of millions over time. And what's in our sort of buy box and who we're sort of attracted to the most is successfully exited founders.

1:33Dominic-Madori Davis: So people like Daniel and like Yalmar, and there's lots of other examples. And when they're motivated to take a bigger swing in usually tangential industries or industries are really passionate about. So yeah, I'm excited to talk more about it and get into it, chop it up.

1:50Farooq Abbasi: Yeah, I was going to ask kind of what drew you to Neco Health, especially because, I mean, it probably makes sense to you as an investor and probably people really deep in the tech world. But because he created Spotify. And so how do you go from Spotify to Neco Health? How was that pitched to you as an investor?

2:07Dominic-Madori Davis: Daniel and Yalmar and Shaq and the people that are involved in that team, they're some of the most talented entrepreneurs that you can find. And if you look at their background, they have been successful in Spotify, in Helsing, also in Neko. And these are projects they care so much about. They invest a lot of their own time into it. And I remember meeting Daniel in 2016 or 2015. And he was talking about this then, about how he wants to fix health care and how in a lot of parts of the world that preventative health care is just not utilized, even in developed countries like in the United States.

2:42Dominic-Madori Davis: I mean, in Europe, I mean, I lived in Europe, as you may remember, Dom, from our last conversation, you know, pretty common to go to the doctor, annual checkup, like clockwork. But, you know, in the United States, there's such little and not just in the U.S. and other parts of the world, there's such little emphasis and focus on preventative care. We solve things when things sort of go awry and sort of ER and the sick population. But there's something that Yalmar has said, not just to me recently and to groups of friends at the NECO launch party event that happened in New York a couple of weeks ago.

3:16Dominic-Madori Davis: But if you look at the Hippocratic Oath, it's prevention is more important than cure. It's been thought about by that team for a long period of time. It's not like a young company. It's like, you know, six, seven years old. It just took a while to sort of build something as impressive as Necco is. And we can we can get into it more. Yeah, I'm just really like honored and happy to be a small part of the journey. And again, there are much other there are other investors in the company like, you know, Lightspeed and OG Partners and a few others. But really happy to support them. Yeah.

3:47Farooq Abbasi: Yeah. And so how did the deal come across your desk, actually? So you already kind of knew them? Yeah.

3:52Dominic-Madori Davis: So I've known I've done some of this team for legitimately like 10 ish, 10 ish years. You know, we've kind of supported each other and kind of different investing initiatives. And, you know, take maybe a step back. I have 35 first cousins who are physicians. My dad and my brother. Yeah. My dad and my brother, both both cardiologists. And actually, like my first role out of out of college was at a venture capital firm, which is Blue Cross Blue Shields venture capital firm. And two really successful companies. One was called Change Healthcare, which went public. I was involved with one was called Freja.

4:25Dominic-Madori Davis: I also was involved with one public. It's just an area that I've cared a lot about. I mean, even for some other examples, like Acasa is a business, which I've incubated with the Andreessen team, which does artificial intelligence or revenue cycle management. That is solving healthcare kind of payment flows and making that whole process a lot better for some of the largest health systems in the world, like HCA, Cleveland Clinic, Mayo. And you'll learn more about them. and hear well learn they've been kind of quieter but they're kind of a secretly very very successful you'll hear more about them pretty soon yeah yeah yeah uh candor health as well in the portfolio and again very consistently like successfully exited founders and experience finding teams and provider directory um resilient health is another primary care business i'm involved with so yeah like health care has been an area that is a just really important that i i care a lot about from a personal perspective.

5:18Dominic-Madori Davis: But I think to answer a question you had earlier, at this point in my career, I'm not like an old, old man or anything. But there are a lot of places to place capital and to partner with people and to have success. In the world right now, people are investing in satellites and in defense and in consumer, like lots of different areas. I am motivated to work with people that I really trust. And those guys are some of the most trustworthy, talented, kind, honorable people that you can find in terms of entrepreneurial teams. So that's one. And then two, from like a philosophical alignment, like this should exist.

5:52And again, more in a personal level too, one of the things that I, I get kind of sad about,

5:58Dominic-Madori Davis: I don't know if you've had this experience, Dom is like, have you ever had a friend who's maybe told you like, Oh, Hey, like, you know, something's like off with my health. And I don't know what it is. And like one of your first responses, like, Hey, you should like just go, why don't you go get that checked out. And they have a fear and they have a fear and they don't want to do it. And it's like, it's such a like, how crazy that we live in a system where there's such a like, friction about like getting the knowledge that you need to take care of yourself. Like that needs to be solved and addressed.

6:27Farooq Abbasi: And so why do you think it's so hard to solve that problem? Because it seems like I mean, there's a lot of healthcare startups. But what is the bottleneck that they're all running into?

6:37Dominic-Madori Davis: Very meaty question. There's a lot of information out there. And also, too, I would just sort of say with healthcare data, it's so much information. And then I think when people look historically, like I'll call it the WebMD effect. You used to go on WebMD and it's like, write what your problem is. And it would say, like, you have something, like your terminal or something kind of terrible. I think there's a little bit of an insecurity with just the human psyche of the unknown. And so that's so that's so kind of critical as their health. That's one. I think from a hospital system perspective, so forget startups for a second.

7:08Dominic-Madori Davis: I I mean, you know, for those who are fortunate to be like insured in the United States, you can get it. You can sign up for an appointment. It takes time. It takes like effort. You don't actually have any cost transparency. I mean, that's that I think also is like it's weird to say this and maybe just to admit it now. I think if I not for myself per se, but I think one of the reasons why people have that fear of like the unknown is because they don't know what it's going to cost them. I mean, 60, 67 percent of bankruptcies in the United States are because of like health care expenses. You just don't know what your copay is.

7:40Dominic-Madori Davis: You don't know what it's going to cost. Like there's just so much issues and sort of difficulty. And what I'm happy about from, I'd say, like the next range of sort of startups, you mentioned a few, right? You mentioned Function Health and there's a few others. There's a couple of problems that need to be solved. First, it's getting information from like the patient and like a standard structured sort of format. And then secondly, it's about translating that information to make it understandable to like a lay person and for them to be able to make interventions in their life, whether it's their own sort of lifestyle choices or maybe prescription, etc.

8:18Dominic-Madori Davis: It's still so unsolved. And so what I love about NECO is, for one, easy to book. Your information is all in one place. It's cost effective.

8:29Farooq Abbasi: How much is it?

8:30Dominic-Madori Davis: About 500 bucks in the United States.

8:32Farooq Abbasi: Does insurance cover it?

8:33Dominic-Madori Davis: No, it's all out of pocket. But I believe at some points in the future, I think it should be reimbursable. I mean, interestingly, if you look at the data behind that, they almost had kind of like a Spotify and review anonymized for like Neko scans and review. Like, first, those who take an echo scan, like 90 % of them, you know, will pay up and want to schedule one for like the next year because they're so happy with the ability and the capability to, A, get all this information, book it, access it. And this information, it's a derm scan. It's a strength test. It's a eye pressure test. It's an echocardiogram.

9:11Dominic-Madori Davis: That's such a thing that is not like done for people who are like under the age of 50, but it's super critical.

9:17Farooq Abbasi: How long does it take? the whole thing. It sounds like expensive.

9:20Dominic-Madori Davis: It is extensive, but it's, but one hour. And what I've loved also too. So you mentioned earlier in my introduction that I've done one scan, I've done two.

9:28Farooq Abbasi: Oh, you've done two scans.

9:29Dominic-Madori Davis: I've done two scans. I've done a generation one scan and then a generation two scan. And again, another reason why like I love this team and their philosophy of like the business, they've made the cost the same. So in my first generation one scan, And it was a blood test with 15 biomarkers. It was 55 this time. And so they're basically adding more and more relevant information and biomarkers for health while doing the best that they can to keep it sort of accessible. I'll say this, and I've even like kind of polled a few of my friends. I asked, like, hey, like, what do you think it should cost?

10:04Dominic-Madori Davis: Or what would you have expected it to cost? It'd be like easily like it could be like$2 ,000,$3 ,000, like no problem. and they make it accessible for people, which is important.

10:16Farooq Abbasi: How do they make it so cheap, I guess, or I guess compared to what it should cost? Like, how is all of that only$500?

10:24Dominic-Madori Davis: Well, okay, should. Should's an interesting word choice. I think preventative care and healthcare should be cheap and accessible. First, like pretty much vertical integration. So first of all, like having like the lab on site. So you get a blood test within the hour And then in that hour period of time, you have like minutes, sometimes tens of minutes, depending with a clinician, with a doctor to actually tell you and have a one on one conversation about like what's going on, what's not going well, what can be sort of improved upon. And again, using the best and next generation of computer vision to identify and get all these biomarkers.

11:03Dominic-Madori Davis: And again, many of these things are going to be approved from an FDA regulatory perspective in the coming months or years to be just directional. And so, again, I haven't seen a company that has given such a comprehensive, also just delightful experience. You feel like you're walking into the future, but a comprehensive, cost-effective primary care visit. like it is leaps and bounds better than anything I've ever seen.

11:28Farooq Abbasi: And well, actually, one thing I do want to know is, so did you were you doing the scans as part of due diligence or was that just like you just wanted to you were just like a regular customer getting scanned?

11:38Dominic-Madori Davis: I mean, again, I've known I've known the founding team for like, like almost a decade. I wanted to just try it to support a friend, to be honest. And like, really, the second that I tried it, I'm like, hey, like, this is pretty incredible. Like, I got to do this. Like, how can I get how can I get involved? And I was very grateful to have the opportunity to, again, like, deploy capital to incentivize problems that should be solved, and that I think are important to solve, like in primary care.

12:09Farooq Abbasi: You know, something that when I think about is like, this is because right now, it's just in New York, right?

12:14Dominic-Madori Davis: No, no, no, it's actually so So HQ is Sweden.

12:19Farooq Abbasi: No, I meant like in the U.S.

12:20Dominic-Madori Davis: Oh, in the U.S., yeah, yeah. So yeah, Sweden. I will say Sweden. There's four, five clinics in the United Kingdom. And then New York, 300 Lafayette. So please, please come. There's a pretty extensive wait list, like quite extensive wait list. But the plan is, you know, like Miami, Los Angeles, Boston, like many, many other cities in the coming months and years.

12:41Farooq Abbasi: It's giving very L.A. to me for some reason. Because like I was just wondering, it's like, what is what is the reality of scaling something like this? Like, could you see this in like rural Mississippi or something? Like, how do you kind of scale a product, not just like Neco Health, but like all the others who are popping up in this market right now?

12:58Dominic-Madori Davis: I mean, I kind of hope and like, again, with the information and knowledge that I have, like, I think there should be Neco clinics like everywhere. I think it's going to eventually kind of not speaking for the team, of course. But, you know, I've worked at a at a at a payers venture capital firm before and understand what incentives are and how things work like this should be reimbursed. Everyone should do it like. Yeah. So how does one scale it? I mean, I would say, look, the company has raised a good amount of capital, which is wonderful. There's some components to equity and debt, which is good to basically like launch launch these clinics.

13:33Dominic-Madori Davis: But they run in an economically intelligent way, despite even being kind of cost effective. Because, I mean, again, these operators like Spotify is a hard business to build and to scale sort of successfully. And like they pulled it off, which is which is epic. Helsing, again, is going the sort of right direction, as I understand it. And Netco is like, you know, flying so far, which is great. So the key thing is making sure that people use it. and it's a booking model and there's you know operations and you can manage costs well but uh this should be everywhere and yeah and in rural clinics yeah hopefully or sorry rural areas hopefully because again like primary care utilization is like ridiculously low in the united states it's like under i think it's under seven or eight percent um that's not good

14:23Farooq Abbasi: Do you think there's any concerns about like the increase of VC backed health startups? Because I was just thinking about how like you, you know, there's this whole thing about like private equity, eating all the hospitals and all these health care things. Are there similar concerns with like the rise of amount of VC backed health startups? Or I guess, where else would the money come from in terms of funding all of these things?

14:48Dominic-Madori Davis: Yeah, that's a great question. I mean, there's a million problems in health care to solve. Like, you know, I actually wish there was more there was more like optimistic dollars, I would say, like to to invest in this, like not just like private equity, squeeze operations, you know, buying surgery care clinics and spinning it off. Like, it's funny, I would say, in my personal opinion, there are some VC dollars that are in the kind of consumerization of health piece, which are overfunding businesses that I don't think will be successful, like long term. And that don't actually drive. So think about like, what's the important thing for in life is to change someone's like health care and sort of patient outcomes.

15:32Dominic-Madori Davis: There are a lot of businesses that are and I won't name specific names because I don't throw a lot of shade here. I try not to throw shade in life, but like the over medicating people and making it ridiculously easy via telemedicine just to be like and they don't think of them as patients. They think of them as subscribers, which is rough. And so and do they have a comprehensive view of someone's health to say that an additional, I don't know, a GLP one or nicotine cessation or like whatever you can subscribe like easily via telemedicine or, you know, or is a or is a blood test that gives you like.

16:08Dominic-Madori Davis: a fancy, I don't know, PDF document and looks pretty and gives you tons of information about possible things that could happen, but it's not really understandable. Somehow for me, it shines a light onto a sector, an area of our world that needs more of our best minds to focus on it and better businesses and better business models. I sometimes get a little disheartened because I'm like, oh, like one of those things got funded again. Like, no, you know, whereas, again, Neko, like, obviously very biased, but, you know, put your money where your mouth is kind of thing. That is a company that will save people.

16:48I mean, like there's some stats.

16:50Dominic-Madori Davis: I mean, they've already saved a couple of people's lives by admitting people to a different hospital system when they needed care, which is pretty amazing.

16:57Farooq Abbasi: Yeah, I was going to ask who kind of handles the follow-ups to this. does NECO have its own system of handling polyps or does it all eventually kind of lead back into the traditional American health system?

17:08Dominic-Madori Davis: It's a better question for the team, for the management team. But as I understand it, if something has popped up, which is important enough to have an intervention, it goes into the sort of the American health system. But again, they just launched in New York and they're going to have clinics. I mean, there's way more to do. Again, the philosophy of NECO is that it's going to be like the place and the sort of like the center hub for people to sort of come back to and benchmark themselves for.

17:34Farooq Abbasi: Based off of all the companies that you invest in, this one included, what are some of the hardest things about building healthcare? I guess I kind of asked the version of this in the beginning, but it seems like, you know, NECO Health, it's so good to be true, right? You know, you have this product and then it just fixes everything. But is this health system like too broken to fix?

17:55Dominic-Madori Davis: Every company today is looking for an edge. Better insights, faster decisions, greater resilience. But as AI drives new growth, it also creates new demands on energy and infrastructure. Schneider Electric is connecting energy, automation, and digital technologies to help organizations make smarter decisions and operate more efficiently. Because the future won't be shaped by AI alone. It will be shaped by energy and industrial intelligence. Schneider Electric, advancing energy tech. I am an optimist. Oh, you're an optimist. I'm compensated to be an optimist to some degree, but I would say no, like nothing's broken to fix.

18:32Dominic-Madori Davis: It's too important of a sector. Look, I mean, the way that I think about it is like, what are problems that like that are the most important that need to be addressed and sort of solved? Primary care utilization is a massive problem. And that is a bet that I have made and really like the NECO team has made to try to fix this. I think another area of issue and concern, I described this earlier in our conversation, is around finance and payments and cost transparency. That hurts. That drives a lot of pain. And so I think the healthcare VC ecosystem needs to support that. And I also think that more people need to come to try to solve these types of problems.

19:13Dominic-Madori Davis: And I've been really happy, I mean, to some degree that historically, like 10 or 15 years ago, the kind of investors and folks and minds that went to sort of healthcare, it was very private equity minded. It was like healthcare services companies. If you looked at what these companies were traded at, even to like when they went public, you can get to a lot of revenue, but they don't trade as well as like some software companies. I mean, if you look at companies like Open Evidence, I mean, like first there's the world is starving for sort of better technology. I mean, are you familiar with Open Evidence, Dom, by chance?

19:46Farooq Abbasi: I don't think so.

19:48Dominic-Madori Davis: Oh, incredible business. Also an investor. It is used by two thirds of doctors every single day. It's recently valued at 15 billion from Andreas Norowitz. And basically it is. It's funny to say chat GPT for doctors, but it's basically like being able to do a sort of Q &A. and double check and upload information. Medical knowledge, the corpus of medical knowledge is doubling every year. There is no way that a doctor, he, she, or they can know all of the information. Mind you, it's all the new information that gets created relevant. But what Open Evidence has done, which is remarkable, is it is partnered and has been inclusive of New England Medical Journal and other publications to basically use that information, train and work together to basically make everyone a super-powered physician or healthcare worker.

20:40Dominic-Madori Davis: Healthcare companies used to take a long time to build, and they would take 10, 15 years to get to a certain scale. I mean, Open Evidence is one of the fastest-growing vertical AI companies around. I mean, when you think about in that world, like Harvey is growing really fast in vertical AI. Glean has grown in vertical applications. You know, Harvey, Legora, you know, Open Evidence, Abridge, maybe, and a few others. But everyone has hated electronic health records. Like people have always, oh, God, it's terrible to work with. We kind of complain. You know, I give credit to Obama and previous administrations for basically pushing through electronic health records.

21:22Dominic-Madori Davis: We have now created a digital work chain of someone's patient, someone's health. And as a result of that sort of standard, relatively standard sort of form of kind of data and sort of set of data constructs, people are able to use artificial intelligence and operationalize and automate and actually make health care even better. So what was something that was like not fashionable and I was like super fashionable, like I don't know, maybe like carpenter jeans or there's probably a better example that doesn't date me so much.

21:54Farooq Abbasi: You said the AI word now. I feel like I have to bring it up. Oh, my God. Well, there's actually there was something I wanted to ask before asking an AI question, which was so so companies like this. And this is like me asking as like a civilian. I know in the venture ecosystem, kind of a win is like a big IPO. But when it comes to these health care companies, should these companies stay private? Or do you see like in ECHO Health or your other investments, the end goal being an IPO where you kind of, I guess, put people's health on the public markets like a lot of hospitals? Or like what is a win for you here?

22:33Dominic-Madori Davis: Oh, what a question. The philosophical answer is in health care. Again, I've been grateful and lucky to have some quite large successes already on the backs of the entrepreneurs that do all the hard work. I want to dedicate and allocate funds to people working on problems that are meaningful material. I also think that the company should go public at some point to be inclusive of the overall population and have people participate as retail shareholders. There is definitely some issues. I think insurance companies being public, that's a little bit sort of like tougher. But, you know, again, I have a somewhat of a bias towards free sort of capital markets.

23:18Dominic-Madori Davis: But I also have a little bit of I think if I could choose, I'd want universal health care. So I'm a little Nordic and I'm a little Nordic in this way, you know.

23:27Farooq Abbasi: No, yeah.

23:28Dominic-Madori Davis: Yeah.

23:28Farooq Abbasi: Do you find that people are actually afraid in terms of AI mixing in with the world of healthcare? Or is that just like talk on the internet?

23:38Dominic-Madori Davis: I think any new technology can have a little bit of like fear associated with it. the problems in healthcare are so remarkably significant. And the impact that one can have is so significant on someone's health and longevity and a healthy population and their use of the costs that are associated with staying healthy and being healthy and being a productive member of society. I think the fears that folks have in artificial intelligence and healthcare are probably overblown relative to the upside. Mind you, if you're using that same filter and framework, surveillance, I mean, I'm negative on that.

24:15Dominic-Madori Davis: Right. So I think like that, I think that the downside of these types of things and what's the upside and who benefits artificial intelligence and health care should make care more accessible, have people like live longer. And of course, there's going to be problems and issues and concerns and edge cases. And, you know, I'm hopeful that the regulatory bodies that kind of monitor these types of technologies and solutions will do the very best that they can. Because, again, I think the world needs to be healthier.

24:44Farooq Abbasi: I did want to ask about regulation because do people kind of see this like or going back to NeccoHealth as an example so this is like preventative do people see this like preventative health do they see it as like a wellness trend a wellness fad um or or are people regulators like the the big decision makers are they actually saying like oh yeah this is like the next frontier

25:07Dominic-Madori Davis: in medicine how are people seeing this I mean again one man's opinion um when I use it when I hear the term like wellness or like fad or let's just say wellness for a second, I can kind of think about like meditation, recovery, cold plunges, saunas, like that type of thing. Neko Health is a medical grade, informative, very high bar for accuracy and for success. And it gives patients actionable insights to make their lives better and to know and actually to measure it. So basically, again, I've worked at Blue Cross Blue Shield a long time ago. So in order to get something, again, there's certain countries are, by the way, Sweden, way better at digital reimbursement.

25:47Dominic-Madori Davis: Really, like reimbursement for health care in the Nordic countries are so wonderful. You want to go to an insurer, whether that's a public or private insurer, and show evidence that like, hey, with the implementation of this technology or process, you're able to have a healthier population that lives longer and you can serve them at lower cost. Neko Health is, in my view thus far, showing all the right signals. And actually, even again, we'll just have more and more folks. I mean, it's already had, I think, hundreds of thousands of scans, and it'll seem to be millions and tens of millions. My suspicion is that there's going to be enough data to show that, hey, because these folks, myself included, have a primary care appointment, and then we're held accountable to that, and then we have the opportunity to speak to a physician.

26:35Dominic-Madori Davis: And there's so many products down that I like I like can't probably don't even have the fullest knowledge about. But like things that are in the in the hopper, it's going to drive real change. And so, again, I'm hopeful that regulators will be excited to be supportive of a company like Neco Health. But I also think they should be careful about those who aren't as robust or maybe aren't as robust or maybe only like capture a very small sliver slice of information and nothing as comprehensive as sort of primary care. You know, that's the difference between what I think is a fad versus what is something that is really like foundational and conventional.

27:15Farooq Abbasi: And I feel like I only have time for one more question, which was you said you have like 30 cousins who are doctors. Yes. First cousins. Have they used Necco Health? What were their thoughts? What do they think needs to be improved on? I'm so curious now.

27:32Dominic-Madori Davis: Okay, well, actually, so my first cousins for physicians are all in Chicago. And unfortunately, there isn't a Necco in Chicago yet. But there will be. No, I mean, honestly, like the feedback largely has been so it's it is just so head and shoulders above any primary care experience that I've ever had. And I think this is why people are so happy to sign up for like the next year and to even share things. I mean, like Neko Health is making ownership of your personal care and primary care like a source of pride. That's why it's on social media. It's on X and people are excited. I know like an SF, I believe it will be on Market Street eventually.

28:13Dominic-Madori Davis: Oh, wait, it's not an SF yet? Will be. Will be.

28:16Farooq Abbasi: Oh, wow. That's actually kind of crazy that it's not in San Francisco yet.

28:19Dominic-Madori Davis: As I understand it, you know, regulatory zoning, these types of things sort of takes time. Still in California. The regulators, I forgot. The regulators, yes. But, you know, like I'm super excited for them to expand there and elsewhere. Because I think, again, this isn't just a U.S. problem. I'm happy it's in Europe. There's more countries there, but it should be really everywhere.

28:40Farooq Abbasi: Yeah. No, it seems like really interesting. It's like all over the Internet now. It seems like a form of like preventative health in a sense. I don't know. I was, I remember I was talking to one, um, have you got, wait, you, you, you

28:51Dominic-Madori Davis: haven't gotten a scan yet.

28:52Farooq Abbasi: I am terrified of these things. Oh no. What?

28:57Dominic-Madori Davis: I just told you the story about, no, we just had a whole conversation. Oh my God. That's so funny. Well, okay. Well, no, that fears are valid. How you feel is valid. Of course. Thank you. I wouldn't. Yeah, of course. I would encourage you to, uh, I would say like the fact that you can interface with a physician for 20 or 30 minutes or 10 minutes or depending on how much time you need privately and ask all those questions. The fact that the data is like secure and that it's yours and it's a really like safe, it's a real safe space. So I would encourage you to, because do you mind me asking when the last time you got a, when's the last time you saw a doctor?

29:32Farooq Abbasi: My primary checkup. I see it once a year.

29:35Dominic-Madori Davis: Oh, you do it. Okay, that's good.

29:37Farooq Abbasi: I'm picking it up, you know, I'm getting in the game. No, I think it, I think it's, I think NECO Health is really, really interesting. And I'm also curious to see how it expands. Yeah. I mean, thank you so much for joining us on the show. Of course. And to our listeners, you can find me on Instagram. Please follow me on Instagram at Dominic Midori. And you can follow equity at equity pod. And where can our listeners find you?

30:01Dominic-Madori Davis: You can email, you know, Farouk at Preface Ventures dot com. For one, always prefer entrepreneurs who are like working on health care problems or artificial intelligence problems, you know, hopefully like from our conversation, some of the themes that I care about are kind of like we're uncovered. And so please, please email me. And then yeah, LinkedIn as well is always good. Thank you, by the way, for the conversation. I hope it was informative. Honestly, I think we could have talked about like more healthcare AI stuff for, for hours, really. Like it's, it's such an interesting time and there's a real renaissance.

30:36Dominic-Madori Davis: So thanks for giving it some attention.

30:39Farooq Abbasi: Yeah, of course. I mean, I I hope there's a renaissance.

30:43Dominic-Madori Davis: It's happening. From just the VC entrepreneurial angle, like it is remarkable, like what's capable now, what's possible, even from like the companies and how fast they're growing and responsibly growing. Like not a fad, not a fad, real.

30:58Farooq Abbasi: Not a fad.

30:59Dominic-Madori Davis: Truly real. So yeah, thank you again.

31:02Farooq Abbasi: Talk to you next time. Talk to you next time. Equity is hosted by TechCrunch Senior Reporters and produced by Teresa Locansolo with editing by Cal. Subscribe on YouTube or wherever you get your podcasts and find out what's next at techcrunch.com slash events. Thanks so much for listening and we'll talk to you next time.